Skip to main content
Fig. 4 | BMC Urology

Fig. 4

From: Combination therapy only shows short-term superiority over monotherapy on ureteral stent-related symptoms – outcome from a randomized controlled trial

Fig. 4

Means of scores of flank pain (a), bladder pain (b) and urgency (c). Effect on flank pain started showing up from day5 to the end (p = 0.006) and solifenacin is comparable to tamsulosin and combination therapy (p = 0.914 vs 0.195) (a). Combination therapy released bladder pain and urgency throughout the whole follow-up (comparing with the control, both p < 0.001) (b and c). Before day4, Solifenacin and tamsulosin had no significant effect on bladder pain (p = 0.589 vs 0.936) or urgency (p = 0.806 vs 0.729) but both showed showed comparable effectiveness as the combination therapy from day5 to day14 (b and c)

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us